Skip to main content
Log in

Characterization of ANF-R2 receptor-mediated inhibition of adenylate cyclase

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

We have characterized the ANF-R2 receptor-mediated inhibition of adenylate cyclase with respect to its modulation by several regulators. ANF (99–126) inhibits adenylate cyclase activity only in the presence of guanine nucleotides. The maximal inhibition (∼ 45%) was observed in the presence of 10-30 μM GTPγS, and at higher concentrations, the inhibitory effect of ANF was completely abolished. ANF-mediated inhibition was not dependent on the presence of monovalent cations, however Na+ enhanced the degree of inhibition by about 60%, whereas K+ and Li+ suppressed the extent of inhibition by about 50%. On the other hand, divalent cation, such as Mn2+ decreased the degree of inhibition in a concentration dependent manner, with an apparent Ki of about 0.7 mM, and at 2 mM; the inhibition was completely abolished. In addition, proteolytic digestion of the membranes with trypsin (40 ng/ml) resulted in the attenuation of ANF-mediated inhibition of adenylate cyclase. Other membrane disrupting agents such as neuraminidase and phospholipase A2 treatments also inhibited completely, the ANF-mediated inhibition of enzyme activity. N-Ethylmaleimide (NEM), phorbol ester and Ca2+-phospholipid dependent protein kinase (C-kinase) which have been shown to interact with inhibitory guanine nucleotide regulating protein (Gi) also resulted in the attenuation of ANF-mediated inhibition of adenylate cyclase activity. These results indicate that in addition to the Gi, the phospholipids and glycoproteins may also play an important role in the expression of ANF-R2 receptor-mediated inhibition of adenylate cyclase.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

ANF:

Atrial Natriuretic Factor

GTPγS:

Guanosine 5′-0-(Thiotriphosphate)

Gi:

inhibitory guanine nucleotide regulatory protein

NEM:

N-Ethylmaleimide

PMA:

Phorbol, 12-Myristate, 13-Acetate, C-kinase, Ca 2+, phospholipid-dependent protein kinase

PHL-A2 :

Phospholipase A,

References

  1. Cantin M, Genest J: The heart as an endocrine gland. Endocr Rev 6: 107–127, 1985

    Google Scholar 

  2. Waldman SA, Rapport RM, Murad F: Atrial natriuretic factor selectively activates particulate guanylate cyclase and elevates cyclic GMP in rat tissues. J Biol Chem 259: 14332–14334, 1984

    Google Scholar 

  3. Tremblay J, Gerzer R, Vinay P, Pang SC, Béliveau R, Hamet P: The increase of cGMP by atrial natriuretic factor correlates with the distribution of particulate guanylate cyclase. FEBS Lett 181: 17–22, 1985

    Google Scholar 

  4. Anand-Srivastava MB, Franks DJ, Cantin M, Genest J: Atrial natriuretic factor inhibits adenylate cyclase activity. Biochem Biophys Res Commun 121: 855–862, 1984

    Google Scholar 

  5. Ishikawa S, Saito T, Okada K, Kuzuya T, Kangawa K, Matsuo H: Atrial natriuretic factor increases cyclic GMP and inhibits cyclic AMP in rat renal papillary collecting tubule cells in culture. Biochem Biophys Res Commun 130: 1147–1153, 1985

    Google Scholar 

  6. Barrett PQ, Isales CM: The role of cyclic nucleotides in atrial natriuretic peptide-mediated inhibition of aldosterone secretion. Endocrinology 122: 799–808, 1988

    Google Scholar 

  7. Anand-Srivastava MB, Vinay P, Genest J, Cantin M: Effect of atrial natriuretic factor on adenylate cyclase in various nephron segments. Am J Physiol 251: F417-F423, 1986

    Google Scholar 

  8. Anand-Srivastava MB, Cantin M: Atrial natriuretic factor receptors are negatively coupled to adenylate cyclase in cultured atrial and ventricular cardiocytes. Biochem Biophys Res Commun 138: 427–436, 1986

    Google Scholar 

  9. Anand-Srivastava MB, Cantin M, Genest J: Inhibition of pitituary adenylate cyclase by atrial natiuretic factor. Life Sci 36: 1873–1879, 1985

    Google Scholar 

  10. Anand-Srivastava MB, Genest J, Cantin M: Inhibitory effect of atrial natriuretic factor on adenylate cyclase activity in adrenal cortical membranes. FEBS Lett 181: 199–202, 1985

    Google Scholar 

  11. Bianchi C, Anand-Srivastava MB, de Lean A, Gutkowska J, Forthomme D, Genest J, Cantin M: Localization and characterization of specific receptors for atrial natriuretic factor in the ciliary processes of the eye. Current Eye Res 5: 283–293, 1986

    Google Scholar 

  12. Leitman D, Anderson JW, Kuno T, Kamisaki Y, Chang JK, Murad F: Identification of multiple binding sites for atrial natriuretic factor by affinity cross-linking in culture endothelial cells. J Biol Chem 261: 11650–11655, 1986

    Google Scholar 

  13. Takayanagi R, Inagami T, Snajdar RM, Imada T, Tamura M, Misono KS: Two distinct forms of receptors for atrial natriuretic factor in bovine adrenocortical cells: Purification, ligand binding, and peptide mapping. J Biol Chem 262: 12104–12113, 1987

    Google Scholar 

  14. Leitman D, Anderson JW, Catalano RM, Waldman SA, Tuan JJ, Murad F: Atrial natriuretic peptide binding, cross-linking, and stimulation of cyclic GMP accumulation and particulate guanylate cyclase activity in cultured cells. J Biol Chem 263: 3720–3728, 1988

    Google Scholar 

  15. Ricard B, Fourguet P, Massacrier A, Courand F: Photoaffinity labeling of ANF receptor in cultured brain neurones. Biochem Biophys Res Commun 152: 1031–1037, 1988

    Google Scholar 

  16. Clinkers M, Garbers DL, Chang MS, Lowe DG, Chin H, Goeddel DV, Schultz S: A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor. Nature 338: 78–83, 1989

    Google Scholar 

  17. Schultz S, Singh S, Bellet RA, Singh G, Tubb DJ, Chin H, Garbers DL: The primary structure of a plasma membrane guanylate cyclase demonstrates diversity within this new receptor family. Cell 58: 1155–1162, 1989

    Google Scholar 

  18. Chang M, Lowe DG, Lewis M, Hellariss R, Chen E, Goeddel DV: Differential activation by atrial and brain natriuretic peptides of two different receptor guanylate eyclases. Nature 341: 68–72, 1989

    Google Scholar 

  19. Fuller F, Porter JG, Arfsten AE, Miller J, Schilling TW, Scarborough RM, Lewicki JA, Schenk DB: Atria( natriuretic peptide clearance receptor: complete sequence and functional expression of cDNA clones. J Biol Chem 263: 9395–9401, 1988

    Google Scholar 

  20. Maack T, Suzuki M, Almeida FA, Nussenzeig D, Scarborough RM, McEnroe GA, Lewicki JA: Physiological role of silent receptors of atrial natriuretic factor. Science 238: 675–678, 1987

    Google Scholar 

  21. Anand-Srivastava MB, Srivastava AK, Cantin M: Pertussis toxin attenuates atrial natriuretic factor-mediated inhibition of adenylate cyclase: involvement of inhibitory guanine nucleotide regulatory protein. J Biol Chem 262: 4931–4934, 1987

    Google Scholar 

  22. Resink TJ, Panchenko MP, Trachuk VA, Buhler FR: Involvement of Ni protein in the functional coupling of the atrial natriuretic factor (ANF) receptor to adenylate cyclase in rat lung plasma membranes. Eur J Biochem 174: 531–535, 1988

    Google Scholar 

  23. Anand-Srivastava MB, Sairam MR, Cantin M: Ring-deleted analogs of atrial natriuretic factor inhibit adenylate cyclase/cAMP system. Possible coupling of clearance atrial natriuretic factor receptors to adenylate cyclase/CAMP signal transduction system. J Biol Chem 265: 8566–8572, 1990

    Google Scholar 

  24. Drewett JG, Ziegler RJ, Trachte CJ: Neuromodulatory effects of atrial natriuretic factor are independent of guanylate cyclase in adrenergic neuronal pheochromocytoma cells. J Pharmacol Expt Therap 255: 497–503, 1990

    Google Scholar 

  25. Katada T, Gilman AH, Watanabe Y, Banes S, Jakobs KH: Protein kinase C phosphorylates the inhibitory guanine-nucleotide-binding regulatory component and apparently suppresses its function in hormonal inhibition of adenylate cyclase. Eur J Biochem 151: 431–437, 1985

    Google Scholar 

  26. Anand-Srivastava MB, Srivastava AK: Modulation of adenylate cyclase activity by Ca2+, phospholipid-dependent protein kinase in rat brain striatum. Mol Cell Biochem 92: 91–98, 1990

    Google Scholar 

  27. Kitamura Y, Nomura Y: Uncoupling of rat cerebral cortical α2-adrenoceptors from GTP-binding proteins by N-ethylmaleimide. J Neurochem 49: 1894–1901, 1987

    Google Scholar 

  28. Salomon Y, Londos C, Rodbell M: A highly sensitive adenylate cyclase assay. Anal Biochem 58: 541–548, 1974

    Google Scholar 

  29. Heisler S, Simard J, Assayag E, Mehri Y, Labrie F: Atrial natriuretic factor does not affect basal, forskolin- and CRF stimulated adenylate cyclase activity, cAMP formation or ACTH secretion, but does stimulate cGMP synthesis in anterior pituitary. Mol Cell Endocrinol 44: 125–131, 1986

    Google Scholar 

  30. Jakobs KH, Aktories K, Minuth M, Schultz G: Inhibition of adenylate cyclase. Adv Cyclic Nucleotide Res 19: 137–150, 1985

    Google Scholar 

  31. Limbird LE, Speck JL, Smith SK: Sodium ion modulates agonist and antagonist interactions with the human platelet Alpha2-adre-nergic receptor in membrane and solubilized preparations. Mol Pharmacol 21: 609–617, 1982

    Google Scholar 

  32. Avissar S, Schreiber G, Danon A, Belmaker RH: Lithium inhibits adrenergic and cholinergic increases in GTP binding in rat cortex. Nature 331: 440–442, 1988

    Google Scholar 

  33. Garbers DL, Johnson RA: Metal and metal-ATP interactions with brain and cardiac adenylate eyclases. J Biol Chem 250: 8449–8456, 1975

    Google Scholar 

  34. Jackowski MM, Johnson RA, Exton JH: Calcium regulation of guanine nucleotide activation of hepatic adenylate cyclase. Biochim Biophys Acta 630: 497–510, 1980

    Google Scholar 

  35. Anand-Srivastava MB: Regulation of adenylate cyclase by adenosine and other agonists in rat myocardial sarcolemma. Arch Biochem Biophys 243: 439–446, 1985

    Google Scholar 

  36. Anand-Srivastava MB, Franks DJ, Cantin M, Genest J: Presence of ‘Ra’ and ‘P’-site receptors for adenosine coupled to adenylate cyclase in cultured vascular smooth muscle cells. Biochem Biophys Res Commun 108: 213–219, 1982

    Google Scholar 

  37. Limbird LE, Lefkowitz RJ: Adenylate-cyclase coupled Beta adrenergic receptors: effect of membrane lipid — perturbing agents on receptor binding and enzyme stimulation by catecholamines. Mol Pharmacol 12: 559–567, 1976

    Google Scholar 

  38. Stengel D, Lad PM, Nielsen TB, Rodbell M, Hanoune J: Proteolysis activates adenylate cyclase in rat liver and AC lymphoma cell independently of the guanine nucleotide regulatory site. FEBS Lett 115: 260–264, 1980

    Google Scholar 

  39. Friedman Y, Wilger J, Crowell D, Burke G: Effects of proteolytic enzymes and protease inhibitors on bovine thyroid adenylate cyclase activity. Endocrinology 112: 1674–1679, 1983

    Google Scholar 

  40. Anderson WB, Jaworski CJ, Vlahakis G: Proteolytic activation of adenylate cyclase form cultured fibroblasts. J Biol Chem 253: 2921–2926, 1978

    Google Scholar 

  41. Stiles GL, Lefkowitz RJ: Hormone-sensitive adenylate cyclase: delineation of a trypsin-sensitive site in the pathway of receptor-mediated inhibition. J Biol Chem 257: 6287–6291, 1982

    Google Scholar 

  42. Liu B, Meloche S, McNicoll N, Lord C, De Lean A: Topographical characterization of the domain structure of the bovine adrenal atrial natriuretic factor R1 receptor. Biochem 28: 5599–5605, 1989

    Google Scholar 

  43. Larsen NE, Mullikin-Kilpatrick D, Blume AJ: Two different modifications of the neuroblastoma × glioma hybrid opiate receptors induced by N-ethylmaleimide. Mol Pharmacol 20: 255–262, 1981

    Google Scholar 

  44. Waldman SA, Rapport RM, Fiscus RR, Murad F: Effects of atriopeptin on particulate guanylate cyclase from rat adrenal. Biochem Biophys Acta 845: 298–303, 1985

    Google Scholar 

  45. Yip CC, Laing LP, Flynn TG: Photoaffinity labeling of atrial natriuretic factor receptors of rad kidney cortex plasma membranes. J Biol Chem 260: 8229–8232, 1985

    Google Scholar 

  46. Lefkowitz RJ: Catecholamine stimulated myocardial adenylate cyclase: effects of phospholipase digestion and the role of membrane lipids. J Mol Cell Cardiol 7: 27–37, 1975

    Google Scholar 

  47. Levey GS: Restoration of norepinephrine responsiveness of solubilized myocardial adenylate cyclase by phosphatidylinositol. J Biol Chem 246: 7405–7410, 1971

    Google Scholar 

  48. Anand-Srivastava MB, Johnson RA: Role of phospholipids in coupling of adenosine and dopamine receptors to striatal adenylate cyclase. J Neurochem 36: 1819–1828, 1981

    Google Scholar 

  49. Azhar S, Hajra M, Menon KMJ: Gonadotropin receptors in plasma membranes of bovine corpus luteum: II Role of membrane phospholipids. J Biol Chem 251: 7405–7412, 1976

    Google Scholar 

  50. Castagna M, Takai Y, Kaibuch K, Sano K, Kikkawa U, Nishizuka Y: Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem 257: 7847–7851, 1982

    Google Scholar 

  51. Katada T, Ui M: ADP ribosylation of the specific membrane protein of C6 cells by Islet-activating protein associated with modification of adenylate cyclase activity. J Biol Chem 257: 7210–7216, 1982

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Anand-Srivastava, M.B. Characterization of ANF-R2 receptor-mediated inhibition of adenylate cyclase. Mol Cell Biochem 113, 83–92 (1992). https://doi.org/10.1007/BF00230889

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00230889

Key words

Navigation